Actieve functies van Andrew Muratore
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| TRILLIUM THERAPEUTICS | Directeur/Bestuurslid | 17-11-2021 | - |
| Corporate Officer/Principal | 17-11-2021 | - |
Loopbaan van Andrew Muratore
Statistieken
Internationaal
| Canada | 2 |
Operationeel
| Director/Board Member | 1 |
| Corporate Officer/Principal | 1 |
Sectoraal
| Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Trillium Therapeutics ULC
 Trillium Therapeutics ULC BiotechnologyHealth Technology Trillium Therapeutics, Inc. is a clinical stage immuno-oncology company, which engages in the research and development of therapies for the treatment of cancer. It offers clinical programs, TTI-621 and TTI-622, target CD47, a signal that cancer cells frequently use to evade the immune system. The company was founded on March 31, 2004 and is headquartered in Mississauga, Canada. | Health Technology |
- Beurs
- Insiders
- Andrew Muratore
- Ervaring
